no code implementations • 12 Aug 2021 • Raphael Ronge, Kwangsik Nho, Christian Wachinger, Sebastian Pölsterl
The current state-of-the-art deep neural networks (DNNs) for Alzheimer's Disease diagnosis use different biomarker combinations to classify patients, but do not allow extracting knowledge about the interactions of biomarkers.
no code implementations • 2 May 2019 • Taeho Jo, Kwangsik Nho, Andrew J. Saykin
The combination of traditional machine learning for classification and stacked auto-encoder (SAE) for feature selection produced accuracies of up to 98. 8% for AD classification and 83. 7% for prediction of conversion from mild cognitive impairment (MCI), a prodromal stage of AD, to AD.